Eagle Global Advisors LLC Pfizer Inc Transaction History

Eagle Global Advisors LLC

$1.96 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $25,310 - $29,659	-1,002 Reduced 11.49%	7,721 $216,000
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $26,537 - $30,473	-1,025 Reduced 10.51%	8,723 $242,000
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $49,777 - $64,655	-1,905 Reduced 16.35%	9,748 $280,000
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $8,022 - $9,377	-250 Reduced 2.1%	11,653 $386,000
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $902 - $1,044	-25 Reduced 0.21%	11,903 $436,000
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $3,899 - $5,076	-99 Reduced 0.82%	11,928 $486,000
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $20,499 - $26,759	-491 Reduced 3.92%	12,027 $616,000
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $5.13 Million - $6.26 Million	-117,206 Reduced 90.35%	12,518 $548,000
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $505,688 - $599,587	-10,868 Reduced 7.73%	129,724 $6.8 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $21,365 - $26,474	-467 Reduced 0.33%	140,592 $7.28 Million
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $5.38 Million - $7.98 Million	130,215 Added 1200.8%	141,059 $8.33 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $5,887 - $7,563	-150 Reduced 1.36%	10,844 $466,000
Q2 2021 Jul 15, 2021	SELL	$35.91 - $40.68 $10,772 - $12,204	-300 Reduced 2.66%	10,994 $431,000
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $18,118 - $20,433	-541 Reduced 4.57%	11,294 $409,000
Q3 2020 Oct 22, 2020	SELL	$31.75 - $37.25 $8,763 - $10,281	-276 Reduced 2.28%	11,835 $434,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $77,137 - $93,578	-2,561 Reduced 17.46%	12,111 $396,000
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $13,515 - $19,310	-500 Reduced 3.3%	14,672 $479,000
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $6,584 - $7,472	-200 Reduced 1.3%	15,172 $594,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $29,630 - $38,422	-912 Reduced 5.6%	15,372 $552,000
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $12,942 - $14,532	-350 Reduced 2.1%	16,284 $705,000
Q1 2019 Apr 22, 2019	BUY	$37.5 - $41.2 $29,062 - $31,930	775 Added 4.89%	16,634 $706,000
Q4 2018 Jan 30, 2019	SELL	$38.47 - $43.86 $13,464 - $15,351	-350 Reduced 2.16%	15,859 $692,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $13,788 - $16,724	-400 Reduced 2.41%	16,209 $714,000
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $9,893 - $10,547	-300 Reduced 1.77%	16,609 $603,000
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $27,123 - $31,467	-850 Reduced 4.79%	16,909 $600,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $550,529 - $606,469	17,759	17,759 $634,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Global Advisors LLC with notifications on news.

Account